Carotid plaque stabilization and progression after stroke or TIA

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 1, 2009, Pages 3-6

  Virmani, Renu ^a   Finn, Aloke V ^b   Kolodgie, Frank D ^a  

^a CVPATH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; COLLAGENASE 3; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; ROSUVASTATIN; STROMELYSIN; STROMELYSIN 3;

ANGIOGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY THROMBOSIS; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY THROMBOSIS; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STROKE; TRANSIENT ISCHEMIC ATTACK; CAROTID ENDARTERECTOMY; NOTE; PATHOLOGY; RUPTURE; SENILE PLAQUE; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; HUMANS; INFLAMMATION; ISCHEMIC ATTACK, TRANSIENT; MUSCLE, SMOOTH, VASCULAR; RUPTURE, SPONTANEOUS; SENILE PLAQUES; STROKE; WOUND HEALING;

EID: 58849083645     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.177659     Document Type: Editorial

References (24)

1. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320-2328.
2. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D. Prevention of disabling and fatal strokes by successful carotid endarter- ectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491-1502.
3. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vase Biol. 2000; 20:1262-1275.
4. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934-940.
5. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999;82:265-268.
6. Wasserman BA, Wityk RJ, Trout HH III, Virmani R. Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke. 2005;36:2504-2513.
7. Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, Pasterkamp G. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vase Biol. 2009;29:128-133.
8. Gijsen FJ, Wentzel JJ, Thury A, Mastik F, Schaar JA, Schuurbiers JC, Slager CJ, van der Giessen WJ, de Feyter PJ, van der Steen AF, Serruys PW. Strain distribution over plaques in human coronary arteries relates to shear stress. Am J Physiol Heart Circ Physiol. 2008;295:H1608-H1614.
9. Groen HC, Gijsen FJ, van der Lugt A, Ferguson MS, Hatsukami TS, Yuan C, van der Steen AF, Wentzel JJ. High shear stress influences plaque vulnerability Part of the data presented in this paper were published in Stroke 2007;38:2379-2381. Neth Heart J. 2008;16:280-283.
10. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-1363.
11. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vase Biol. 2002;22:1642-1648.
12. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852.
13. Burke AP, Virmani R, Galis Z, Haudenschild CC, Muller JE. 34th Bethesda Conference: Task force #2-What is the pathologic basis for new atherosclerosis imaging techniques? J Am Coll Cardiol. 2003;41:1874-1886.
14. Hunt JL, Fairman R, Mitchell ME, Carpenter JP, Golden M, Khalapyan T, Wolfe M, Neschis D, Milner R, Scoll B, Cusack A, Mohler ER, III. Bone formation in carotid plaques: a clinicopathological study. Stroke. 2002;33:1214-1219.
15. Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT, Virmani R. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vase Biol. 2006;26:2523-2529.
16. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316-2325.
17. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med. 2008;121:S21-S31.
18. Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vase Biol. 2008;28:128-133.
19. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
20. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial colla-genases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999;99:2503-2509.
21. Hao H, Gabbiani G, Camenzind E, Bacchetta M, Virmani R, Bochaton-Piallat ML. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vase Biol. 2006;26:326-332.
22. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y, Smialek J, Virmani R. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol. 2000;157:1259-1268.
23. Kleemann R, Princen HM, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJ, Kooistra T, Havekes LM. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin. Circulation. 2003;108:1368-1374.
24. Rezaie-Majd A, Maca T, Bucek RA, Valent P, Muller MR, Husslein P, Kashanipour A, Minar E, Baghestanian M. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte che-moattractant protein-1 in circulating monocytes from hypercholesterol-emic patients. Arterioscler Thromb Vase Biol. 2002;22:1194-1199.